Julie M Herlihy1, Leoda Hamomba, Rachael Bonawitz, Caitlin E Goggin, Kennedy Sambambi, Jonas Mwale, Victor Musonda, Kebby Musokatwane, Kathryn L Hopkins, Katherine Semrau, Emily E Hammond, Julie Duncan, Anna B Knapp, Donald M Thea. 1. *Center for Global Health and Development, Boston University School of Public Health, Boston, MA; †Department of Pediatrics, Boston Medical Center, Boston, MA; ‡Department of Global Health, Boston University School of Public Health, Boston, MA; §Department of Pediatrics, University of California Davis, Sacramento, CA; ‖Zambia Center for Applied Health Research and Development, Lusaka, Zambia; ¶Marie Stopes International, Lilongwe, Malawi; #Centers for Disease Control and Prevention, Lusaka, Zambia; **Ministry of Community Development, Mother and Child Health, Government of the Republic of Zambia, Lusaka, Zambia; and ††Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa.
Abstract
BACKGROUND: Early initiation of combination antiretroviral therapy (cART) for HIV-positive pregnant women can decrease vertical transmission to less than 5%. Programmatic barriers to early cART include decentralized care, disease-stage assessment delays, and loss to follow-up. INTERVENTION: Our intervention had 3 components: integrated HIV and antenatal services in 1 location with 1 provider, laboratory courier to expedite CD4 counts, and community-based follow-up of women-infant pairs to improve prevention of mother-to-child transmission attendance. Preintervention HIV-positive pregnant women were referred to HIV clinics for disease-stage assessment and cART initiation for advanced disease (CD4 count <350 cells/μL or WHO stage >2). METHODS: We used a quasi-experimental design with preintervention/postintervention evaluations at 6 government antenatal clinics (ANCs) in Southern Province, Zambia. Retrospective clinical data were collected from clinic registers during a 7-month baseline period. Postintervention data were collected from all antiretroviral therapy-naive, HIV-positive pregnant women and their infants presenting to ANC from December 2011 to June 2013. RESULTS: Data from 510 baseline women-infant pairs were analyzed and 624 pregnant women were enrolled during the intervention period. The proportion of HIV-positive pregnant women receiving CD4 counts increased from 50.6% to 77.2% [relative risk (RR) = 1.81; 95% confidence interval (CI): 1.57 to 2.08; P < 0.01]. The proportion of cART-eligible pregnant women initiated on cART increased from 27.5% to 71.5% (RR = 2.25; 95% CI: 1.78 to 2.83; P < 0.01). The proportion of eligible HIV-exposed infants with documented 6-week HIV PCR test increased from 41.9% to 55.8% (RR = 1.33; 95% CI: 1.18 to 1.51; P < 0.01). CONCLUSIONS: Integration of HIV care into ANC and community-based support improved uptake of CD4 counts, proportion of cART-eligible women initiated on cART, and infants tested.
BACKGROUND: Early initiation of combination antiretroviral therapy (cART) for HIV-positive pregnant women can decrease vertical transmission to less than 5%. Programmatic barriers to early cART include decentralized care, disease-stage assessment delays, and loss to follow-up. INTERVENTION: Our intervention had 3 components: integrated HIV and antenatal services in 1 location with 1 provider, laboratory courier to expedite CD4 counts, and community-based follow-up of women-infant pairs to improve prevention of mother-to-child transmission attendance. Preintervention HIV-positive pregnant women were referred to HIV clinics for disease-stage assessment and cART initiation for advanced disease (CD4 count <350 cells/μL or WHO stage >2). METHODS: We used a quasi-experimental design with preintervention/postintervention evaluations at 6 government antenatal clinics (ANCs) in Southern Province, Zambia. Retrospective clinical data were collected from clinic registers during a 7-month baseline period. Postintervention data were collected from all antiretroviral therapy-naive, HIV-positive pregnant women and their infants presenting to ANC from December 2011 to June 2013. RESULTS: Data from 510 baseline women-infant pairs were analyzed and 624 pregnant women were enrolled during the intervention period. The proportion of HIV-positive pregnant women receiving CD4 counts increased from 50.6% to 77.2% [relative risk (RR) = 1.81; 95% confidence interval (CI): 1.57 to 2.08; P < 0.01]. The proportion of cART-eligible pregnant women initiated on cART increased from 27.5% to 71.5% (RR = 2.25; 95% CI: 1.78 to 2.83; P < 0.01). The proportion of eligible HIV-exposed infants with documented 6-week HIV PCR test increased from 41.9% to 55.8% (RR = 1.33; 95% CI: 1.18 to 1.51; P < 0.01). CONCLUSIONS: Integration of HIV care into ANC and community-based support improved uptake of CD4 counts, proportion of cART-eligible women initiated on cART, and infants tested.
Authors: Erik J Schouten; Andreas Jahn; Dalitso Midiani; Simon D Makombe; Austin Mnthambala; Zengani Chirwa; Anthony D Harries; Joep J van Oosterhout; Tarek Meguid; Anne Ben-Smith; Rony Zachariah; Lutgarde Lynen; Maria Zolfo; Wim Van Damme; Charles F Gilks; Rifat Atun; Mary Shawa; Frank Chimbwandira Journal: Lancet Date: 2011-07-16 Impact factor: 79.321
Authors: Baotran N Vo; Craig R Cohen; Rachel M Smith; Elizabeth A Bukusi; Maricianah A Onono; Katie Schwartz; Sierra Washington; Janet M Turan Journal: AIDS Care Date: 2012-02-01
Authors: R L Shapiro; M D Hughes; A Ogwu; D Kitch; S Lockman; C Moffat; J Makhema; S Moyo; I Thior; K McIntosh; E van Widenfelt; J Leidner; K Powis; A Asmelash; E Tumbare; S Zwerski; U Sharma; E Handelsman; K Mburu; O Jayeoba; E Moko; S Souda; E Lubega; M Akhtar; C Wester; R Tuomola; W Snowden; M Martinez-Tristani; L Mazhani; M Essex Journal: N Engl J Med Date: 2010-06-17 Impact factor: 91.245
Authors: William P Killam; Bushimbwa C Tambatamba; Namwinga Chintu; Dwight Rouse; Elizabeth Stringer; Maximillian Bweupe; Yong Yu; Jeffrey Sa Stringer Journal: AIDS Date: 2010-01-02 Impact factor: 4.177
Authors: Lawrence Long; Alana Brennan; Matthew P Fox; Buyiswa Ndibongo; Imogen Jaffray; Ian Sanne; Sydney Rosen Journal: PLoS Med Date: 2011-07-19 Impact factor: 11.069
Authors: James T Pfeiffer; Manuel Napúa; Bradley H Wagenaar; Falume Chale; Roxanne Hoek; Mark Micek; João Manuel; Cathy Michel; Jessica Greenberg Cowan; James F Cowan; Sarah Gimbel; Kenneth Sherr; Stephen Gloyd; Rachel R Chapman Journal: J Acquir Immune Defic Syndr Date: 2017-11-01 Impact factor: 3.731
Authors: Kathleen Miller; Winnie Muyindike; Lynn T Matthews; Michael Kanyesigye; Mark J Siedner Journal: AIDS Patient Care STDS Date: 2017-06-26 Impact factor: 5.078
Authors: Eunice Wambui Nduati; Amin Shaban Hassan; Miguel Garcia Knight; Daniel Muli Muema; Margaret Nassim Jahangir; Shalton Lwambi Mwaringa; Timothy Juma Etyang; Sarah Rowland-Jones; Britta Christina Urban; James Alexander Berkley Journal: BMC Public Health Date: 2015-10-03 Impact factor: 3.295
Authors: McKenna C Eastment; John Kinuthia; Lei Wang; George Wanje; Katherine Wilson; Anne Kaggiah; Jane M Simoni; Kishorchandra Mandaliya; Danielle N Poole; Barbra A Richardson; Walter Jaoko; Grace John-Stewart; R Scott McClelland Journal: PLoS One Date: 2021-07-19 Impact factor: 3.240
Authors: Rebecca Matheson; Suzette Moses-Burton; Amy C Hsieh; Sophie Dilmitis; Margaret Happy; Eunice Sinyemu; Sophie O Brion; Aditi Sharma Journal: J Int AIDS Soc Date: 2015-12-01 Impact factor: 5.396